Business
Pervasip Corp. Asset KRTL Biotech Inc. Welcomes Agtech Global International Inc. to its Psilocybin Research Project in South Korea
Pervasip Corp. Asset KRTL Biotech Inc. Welcomes Agtech Global International Inc. to its Psilocybin Research Project in South Korea.
About this update from Pervasip Corp.
[{"type":"text","content":"Seattle, Washington--(Newsfile Corp. - October 25, 2021) - Pervasip Corp. (OTC PINK: PVSP), a developer of companies and technologies in high value emerging markets, the 100% owner of Artizen Corporation, and the 5% owner of KRTL Biotech Inc (\"KRTL\"), is pleased to announce that KRTL has signed a memorandum of understanding with Agtech Global International Inc. (OTC:AGGL) (\"Agtech\") to join its race to develop compounds and ultimately novel medicines using psilocybin and other naturally occurring medicines to help fight a vast array of mental and physical ailments such as PTSD, ADHD, depression, addiction, cancer, and autism.The Co-Chief Executive Officer of KRTL, Kai Kim, said, \"KRTL is quickly developing a project with the assistance of several public companies looking to enter what management believes will be a disruptive opportunity in medicine within the next decade. Corporate partners such as Pervasip Corp. and Agtech share in the vision of KRTL becoming a leader in psilocybin research.\" \"We are pleased to say that KRTL's CEO, Dr. DaeHee Lee, has been recognized by the National Cancer Center and has over 90 published research papers,\" continued Mr. Kim. \"Agtech has pledged a cash investment of $2,000,000 for KRTL, and we believe the investment combined with our world-class team of researchers will obtain significant results in our plan to create new medicines.\"KRTL's website is Home | KRTL Biotech Inc and its Twitter account is https://twitter.com/KRTLBiotech.About Artizen CorporationArtizen Corporation (\"Artizen\") is a diversified asset management company that was founded to acquire, develop, and support companies and technologies in the emerging cannabis industry. Artizen primarily does so in Washington state today, where it generates revenue by providing leasing, licensing, management, staffing, and supplies to cannabis production facilities. Artizen's existing clients operate five licensed cannabis cultivation and processing facilities in Washington, with about 120,000 square feet of canopy, of which only about 50,000 square feet is currently used. Most of the biomass produced by those facilities has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. For more information, visit: www.artizencannabis.com. Forward-Looking StatementsThis...